You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ponesimod

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Merksem (Ponesimod, Carbamazepine)

Recruiting
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jan 31, 2023

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Multiple Sclerosis Trial in Worldwide (Ponesimod)

Active, not recruiting
  • Multiple Sclerosis
  • Ponesimod
  • Carlsbad, California
  • +147 more
Aug 16, 2022

Multiple Sclerosis Trial in Worldwide (ponesimod, teriflunomide)

Completed
Has Results
  • Multiple Sclerosis
  • Carlsbad, California
  • +161 more
Jan 24, 2022

Multiple Sclerosis Trial in Worldwide (Ponesimod, Placebo)

Terminated
Has Results
  • Multiple Sclerosis
  • Ponesimod
  • Placebo
  • Birmingham, Alabama
  • +118 more
Apr 27, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Multiple Sclerosis Trial in Worldwide (ACT-128800 Dose 1, Placebo, ACT-128800 Dose 2)

Completed
Has Results
  • Multiple Sclerosis
  • ACT-128800 Dose 1
  • +3 more
  • Scottsdale, Arizona
  • +114 more
Feb 4, 2022

Chronic GVHD Trial in United States (Ponesimod)

Terminated
Has Results
  • Chronic Graft Versus Host Disease
  • Ponesimod
  • Scottsdale, Arizona
  • +9 more
Apr 9, 2018

Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Chisinau, Moldova, Republic of
    Republican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Aggressive Therapy or Traditional Therapy
  • Birmingham, Alabama
  • +51 more
Jan 23, 2023

Healthy Trial in Merthyr Tydfil (Ponesimod 5mg i.v., Ponesimod i.v., Ponesimod 10 mg tablet)

Completed
  • Healthy
  • Ponesimod 5mg i.v.
  • +2 more
  • Merthyr Tydfil, United Kingdom
    Simbec Research Limited
May 20, 2015

Healthy Trial in Evansville (Ponesimod Placebo, Moxifloxacin Placebo, Ponesimod 10 mg)

Completed
  • Healthy
  • Ponesimod Placebo
  • +8 more
  • Evansville, Indiana
    Covance Clinical Research Unit (CRU)
May 12, 2014

Healthy Trial in Honolulu (ACT-128800)

Completed
  • Healthy
  • Honolulu, Hawaii
    Hawaii Clinical Research Center
Aug 21, 2014

Pharmacokinetics Trial in Allschwil (ACT-128800)

Completed
  • Pharmacokinetics
  • Allschwil, Switzerland
    Swiss Pharma Contract
Apr 29, 2014

Safety and Tolerability Trial in London (ACT-128800, Placebo)

Completed
  • Safety and Tolerability
  • London, United Kingdom
    Quintiles Drug Research Unit at Guy's Hospital
Jan 6, 2014

Psoriasis Trial in Worldwide (ACT-128800, Placebo)

Completed
  • Psoriasis
  • Feldkirch, Austria
  • +67 more
Jan 23, 2013

Plaque Psoriasis Trial in Worldwide (ACT-128800, Placebo)

Completed
  • Plaque Psoriasis
  • Graz, Austria
  • +13 more
Nov 11, 2009